On this page:Overview Publications Researchers Key papers Journals Open access Institutions

ScholarIQanswers from OpenAlex

Cancer Treatment and Pharmacology

TopicLeading institutions, researchers & key papers

Cancer Treatment and Pharmacology is a topic indexed in ScholarIQ from OpenAlex.

What is known about Cancer Treatment and Pharmacology?

ScholarIQrecord summary

This cluster of papers focuses on the chemotherapy-induced peripheral neuropathy (CIPN) experienced by cancer patients, particularly in the context of breast cancer treatment. It covers various aspects such as the neurotoxic effects of taxanes and oxaliplatin, neuroprotective strategies, and the impact of CIPN on the quality of life of patients. Additionally, it discusses the use of microtubule-targeting agents like Eribulin Mesylate in cancer treatment.

How many works does Cancer Treatment and Pharmacology have?

ScholarIQindexed works

Cancer Treatment and Pharmacology has 302 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

See the works listed for Cancer Treatment and Pharmacology →

What is the OpenAlex record for Cancer Treatment and Pharmacology?

ScholarIQopenalex

The OpenAlex for Cancer Treatment and Pharmacology is on the source record.

Open the OpenAlex →

What are the most-cited papers on Cancer Treatment and Pharmacology?

ScholarIQmost cited works

A simple method for clinical assay of superoxide dismutase.

Yi Sun, L. W. Oberley, Yi Li

Clinical Chemistry. 19884,485 Citations

Paclitaxel plus Bevacizumab versus Paclitaxel Alone for Metastatic Breast Cancer

Kathy D. Miller, Molin Wang, Julie R. Gralow, Maura N. Dickler, Melody Cobleigh, Edith A. Perez, Tamara Shenkier, David Cella, Nancy E. Davidson

New England Journal of Medicine. 20073,066 CitationsOPEN ACCESS

Phase III Trial of Nanoparticle Albumin-Bound Paclitaxel Compared With Polyethylated Castor Oil–Based Paclitaxel in Women With Breast Cancer

William J. Gradishar, Sergei Tjulandin, Neville Davidson, Heather Shaw, Neil Desai, Paul Bhar, Michael Hawkins, Joyce O’Shaughnessy

Journal of Clinical Oncology. 20052,143 CitationsOPEN ACCESS

A History of Cancer Chemotherapy

Vincent T. DeVita, Edward Chu

Cancer Research. 20081,955 CitationsOPEN ACCESS

Breast Cancer, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology

William J. Gradishar, Benjamin O. Anderson, Jame Abraham, Rebecca Aft, Doreen M. Agnese, Kimberly H. Allison, Sarah L. Blair, Harold J. Burstein, Chau T. Dang, Anthony Elias, Sharon H. Giordano, Matthew P. Goetz, Lori J. Goldstein, Steven J. Isakoff, Jairam Krishnamurthy, Janice A. Lyons, P. Kelly Marcom, Jennifer M. Matro, Ingrid A. Mayer, Meena S. Moran, Joanne Mortimer, Ruth O’Regan, Sameer A. Patel, Lori J. Pierce, Hope S. Rugo, Amy M. Sitapati, Karen L. Smith, Mary Lou Smith, Hatem Soliman, Erica Stringer-Reasor, Melinda L. Telli, John H. Ward, Jessica Young, Jennifer L. Burns, Rashmi Kumar

Journal of the National Comprehensive Cancer Network. 20201,624 CitationsOPEN ACCESS

Where is Cancer Treatment and Pharmacology research published, and who funds it?

ScholarIQvenues & funding sources

TOP JOURNALS

Journal of Clinical Oncology6,805

Clinical Chemistry4,485

New England Journal of Medicine3,066

Cancer Research1,955

Journal of the National Comprehensive Cancer Network1,624

TOP FUNDERS

National Science Foundation—

NIH—

Wellcome Trust—

European Research Council—

Funder breakdown is a member featureSign up free to unlock

How much of the research on Cancer Treatment and Pharmacology is open access?

ScholarIQopen access share

47%OPEN ACCESS

Gold

Green

Hybrid

Bronze

33%

Closed

53%